Aehr Test Systems (NASDAQ:AEHR) Receives $21.00 Consensus Target Price from Analysts

Aehr Test Systems (NASDAQ:AEHR) has received an average recommendation of “Hold” from the five ratings firms that are covering the stock, MarketBeat reports. One research analyst has rated the stock with a sell recommendation, two have given a hold recommendation and two have assigned a buy recommendation to the company. The average 12 month price target among brokers that have issued ratings on the stock in the last year is $21.00.

AEHR has been the subject of several recent analyst reports. Lake Street Capital started coverage on Aehr Test Systems in a research note on Wednesday, December 17th. They set a “buy” rating for the company. William Blair upgraded Aehr Test Systems from a “market perform” rating to an “outperform” rating in a research note on Monday, March 2nd. Zacks Research raised Aehr Test Systems from a “strong sell” rating to a “hold” rating in a report on Monday, December 8th. Weiss Ratings restated a “sell (d)” rating on shares of Aehr Test Systems in a research note on Wednesday, January 21st. Finally, Craig Hallum restated a “hold” rating on shares of Aehr Test Systems in a report on Friday, January 9th.

Aehr Test Systems Trading Down 12.1%

Shares of AEHR stock opened at $35.61 on Monday. The firm has a fifty day simple moving average of $29.17 and a 200-day simple moving average of $26.60. The company has a market capitalization of $1.09 billion, a PE ratio of -118.70 and a beta of 2.22. Aehr Test Systems has a twelve month low of $6.27 and a twelve month high of $46.95.

Aehr Test Systems (NASDAQ:AEHR) last released its quarterly earnings results on Thursday, January 8th. The semiconductor company reported ($0.04) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.08) by $0.04. The firm had revenue of $9.88 million for the quarter, compared to the consensus estimate of $11.45 million. Aehr Test Systems had a negative net margin of 16.63% and a negative return on equity of 4.57%. Equities research analysts predict that Aehr Test Systems will post 0.1 EPS for the current year.

Insider Buying and Selling

In related news, Director Laura Oliphant sold 4,546 shares of the company’s stock in a transaction on Thursday, January 22nd. The shares were sold at an average price of $31.40, for a total value of $142,744.40. Following the sale, the director directly owned 18,432 shares of the company’s stock, valued at $578,764.80. This represents a 19.78% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Rhea J. Posedel sold 13,998 shares of the stock in a transaction on Friday, February 13th. The shares were sold at an average price of $30.02, for a total transaction of $420,219.96. Following the transaction, the director owned 456,979 shares in the company, valued at $13,718,509.58. This trade represents a 2.97% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. 6.80% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On Aehr Test Systems

Several hedge funds and other institutional investors have recently modified their holdings of the stock. William Blair Investment Management LLC bought a new position in shares of Aehr Test Systems during the third quarter worth about $26,920,000. Wellington Management Group LLP grew its stake in Aehr Test Systems by 129.9% in the fourth quarter. Wellington Management Group LLP now owns 830,664 shares of the semiconductor company’s stock worth $16,771,000 after purchasing an additional 469,400 shares in the last quarter. Kennedy Capital Management LLC bought a new stake in Aehr Test Systems in the second quarter valued at about $5,751,000. Invesco Ltd. increased its holdings in Aehr Test Systems by 1,137.2% in the third quarter. Invesco Ltd. now owns 366,570 shares of the semiconductor company’s stock valued at $11,037,000 after buying an additional 336,940 shares during the last quarter. Finally, Next Century Growth Investors LLC raised its stake in Aehr Test Systems by 99.9% during the fourth quarter. Next Century Growth Investors LLC now owns 552,506 shares of the semiconductor company’s stock valued at $11,155,000 after buying an additional 276,160 shares in the last quarter. Institutional investors own 69.69% of the company’s stock.

About Aehr Test Systems

Aehr Test Systems develops, manufactures and sells semiconductor test and burn-in equipment used by device manufacturers to ensure quality and reliability of integrated circuits. Its products are designed for wafer-level reliability assessment, functional test and stress screening of memory devices, system-on-chips, optical components and power semiconductors. By focusing on wafer-level burn-in and testing processes, the company helps reduce cost and improve yield for high-volume semiconductor production.

The company’s product portfolio includes FOX series wafer probe test and burn-in systems as well as ABTS burn-in ovens.